Newswise — In a true example of bench-to-bedside science, researchers at UC San Diego have identified the cause of a rare skin disorder, disabling pansclerotic morphea, and swiftly identified a treatment that dramatically improved patients’ symptoms. 

The scientists discovered that the patients have an overactive version of a protein called STAT4, and that the drug ruxolitinib improved patients’ rashes and ulcers. 

The results were published in the New England Journal of Medicine.

DOI: 10.1056/NEJMoa2202318

University of California San Diego

Source link

You May Also Like

U-Haul driver fleeing police critically injures man in Queens hit-and-run

The driver of a stolen U-Haul fleeing from police critically injured a…

Al Pacino, 83, expecting fourth child

Al Pacino will become a father for the fourth time, his representatives…

Minnesota Legislature considering 2 gun control proposals

ST. PAUL, Minn. — The Minnesota House was considering a “red flag…

Impeached Texas AG Ken Paxton partnered with troubled businessman to push opioid program

This article is co-published with ProPublica, a nonprofit newsroom that investigates abuses…